Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- No established or recommended human dose. The failed Phase II postoperative study used 0.03 mg/kg IV twice daily from postoperative day 1 through day 7 or hospital discharge. That protocol-specific exposure was not a dose recommendation and did not establish efficacy.